Toxins of Clostridium perfringens types A, Pharmacology of bacterial toxins, pp.477-517, 1986. ,
Molecular basis of toxicity of Clostridium perfringens epsilon toxin, FEBS J, vol.278, pp.4589-4601, 2011. ,
Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: A review, Aust Vet J, vol.81, pp.219-221, 2003. ,
High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain, Infect Immun, vol.60, pp.1237-1240, 1992. ,
Binding of epsilon-toxin from Clostridium perfringens in the nervous system, Vet Microbiol, vol.131, pp.14-25, 2008. ,
Epsilon toxin from Clostridium perfringens acts on oligodendrocytes without forming pores, and causes demyelination, Cell Microbiol, vol.17, pp.369-388, 2015. ,
Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells, Toxicon, vol.50, pp.530-540, 2007. ,
Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release, PLoS ONE, vol.5, p.13046, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01762143
Epsilon toxin: A fascinating poreforming toxin, FEBS J, vol.278, pp.4602-4615, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01791200
Clostridium welchii epsilon toxin in the intestinal contents of man, Lancet, vol.268, pp.384-385, 1955. ,
Recovery of Clostridium welchii type D from man, Lancet, vol.268, p.385, 1955. ,
Isolation of Clostridium perfringens type B in an individual ,
Acute effect of pore-forming Clostridium perfringens ?-toxin on compound action potentials of optic nerve of mouse, vol.4, pp.51-68, 2017. ,
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann Neurol, vol.69, pp.292-302, 2011. ,
Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin, Nat Struct Mol Biol, vol.11, pp.797-798, 2004. ,
Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia, Vaccine, vol.32, pp.2682-2687, 2014. ,
Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus, J Virol, vol.64, pp.3304-3309, 1990. ,
The myelin and lymphocyte protein MAL is required for binding and activity of Clostridium perfringens ?-toxin, PLoS Pathog, vol.11, p.1004896, 2015. ,
MAL, a proteolipid in glycosphingolipid enriched domains: Functional implications in myelin and beyond, Prog Neurobiol, vol.60, pp.531-544, 2000. ,
The role of antibodies in multiple sclerosis, Biochim Biophys Acta, vol.1812, pp.239-245, 2011. ,
Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis, Lancet Neurol, vol.4, pp.281-288, 2005. ,
Clinically isolated syndromes and the relationship to multiple sclerosis, J Clin Neurosci, vol.21, pp.2065-2071, 2014. ,
Efficient generation of a reshaped human mAb specific for the alpha toxin of Clostridium perfringens, Protein Eng, vol.7, pp.1501-1507, 1994. ,
Subdomains of ricin's B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies, PLoS ONE, vol.7, p.44317, 2012. ,
Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens, Ann Neurol, vol.80, pp.443-447, 2016. ,
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice, Proc Natl Acad Sci, vol.114, pp.10719-10724, 2017. ,
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models, Proc Natl Acad Sci, vol.114, pp.10713-10718, 2017. ,
Alterations of the human gut microbiome in multiple sclerosis, Nat Commun, vol.7, p.12015, 2016. ,
Gut microbiota composition and relapse risk in pediatric MS: A pilot study, J Neurol Sci, vol.363, pp.153-157, 2016. ,